Insmed Incorporated (INSM)

Insmed Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	447.02	363.71	305.21	245.36	188.46	164.41
Revenue Growth (YoY)	30.34%	19.17%	24.39%	30.19%	14.63%	20.48%
Cost of Revenue	104.87	85.74	65.57	55.13	44.15	39.87
Gross Profit	342.15	277.97	239.64	190.23	144.31	124.54
Selling, General & Admin	631.2	461.12	344.5	265.78	233.67	203.61
Research & Development	695.91	598.37	571.01	397.52	272.74	181.16
Amortization of Goodwill & Intangibles	5.33	5.05	5.05	5.05	5.05	5
Operating Expenses	1,332	1,065	920.56	668.36	511.47	389.77
Operating Income	-990.28	-786.57	-680.93	-478.12	-367.16	-265.23
Interest Expense	-83.88	-85.15	-81.37	-27.97	-40.47	-29.56
Interest & Investment Income	62.68	53.31	42.13	11.08	0.17	1.7
Other Non Operating Income (Expenses)	-0.46	0.03	1.86	-5.94	-3.33	0.41
EBT Excluding Unusual Items	-1,012	-818.38	-718.32	-500.95	-410.79	-292.69
Merger & Restructuring Charges	-	-	-	-	-0.6	-
Other Unusual Items	-167.15	-91.68	-28.7	20.8	-25.02	-
Pretax Income	-1,179	-910.07	-747.01	-480.15	-436.41	-292.69
Income Tax Expense	4.74	3.71	2.56	1.38	-1.76	1.4
Net Income	-1,184	-913.77	-749.57	-481.53	-434.65	-294.09
Net Income to Common	-1,184	-913.77	-749.57	-481.53	-434.65	-294.09
Shares Outstanding (Basic)	190	164	140	123	112	98
Shares Outstanding (Diluted)	190	164	140	123	112	98
Shares Change (YoY)	22.43%	16.81%	14.14%	9.74%	14.86%	15.43%
EPS (Basic)	-6.22	-5.57	-5.34	-3.91	-3.88	-3.01
EPS (Diluted)	-6.22	-5.57	-5.34	-3.91	-3.88	-3.01
Free Cash Flow	-906.14	-705.81	-549.54	-410.32	-370.59	-225.59
Free Cash Flow Per Share	-4.76	-4.30	-3.91	-3.33	-3.31	-2.31
Gross Margin	76.54%	76.43%	78.52%	77.53%	76.57%	75.75%
Operating Margin	-221.53%	-216.27%	-223.10%	-194.87%	-194.82%	-161.32%
Profit Margin	-264.83%	-251.24%	-245.59%	-196.26%	-230.63%	-178.87%
Free Cash Flow Margin	-202.71%	-194.06%	-180.05%	-167.23%	-196.64%	-137.21%
EBITDA	-978.79	-777.7	-672.49	-465.83	-351.9	-250
EBITDA Margin	-218.96%	-213.82%	-220.34%	-189.86%	-186.72%	-152.06%
D&A For EBITDA	11.49	8.88	8.44	12.29	15.26	15.23
EBIT	-990.28	-786.57	-680.93	-478.12	-367.16	-265.23
EBIT Margin	-221.53%	-216.27%	-223.10%	-194.87%	-194.82%	-161.32%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q